ZA202210419B - Influenza virus-like particles (vlps) - Google Patents
Influenza virus-like particles (vlps)Info
- Publication number
- ZA202210419B ZA202210419B ZA2022/10419A ZA202210419A ZA202210419B ZA 202210419 B ZA202210419 B ZA 202210419B ZA 2022/10419 A ZA2022/10419 A ZA 2022/10419A ZA 202210419 A ZA202210419 A ZA 202210419A ZA 202210419 B ZA202210419 B ZA 202210419B
- Authority
- ZA
- South Africa
- Prior art keywords
- vlps
- particles
- influenza virus
- influenza
- virus
- Prior art date
Links
- 206010022000 influenza Diseases 0.000 title 1
- 239000002245 particle Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/295—Polyvalent viral antigens; Mixtures of viral and bacterial antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/145—Orthomyxoviridae, e.g. influenza virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/62—DNA sequences coding for fusion proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5258—Virus-like particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
- A61K2039/543—Mucosal route intranasal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16123—Virus like particles [VLP]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/20011—Coronaviridae
- C12N2770/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Virology (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Pulmonology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Plant Pathology (AREA)
- Communicable Diseases (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP20169787.7A EP3896077A1 (en) | 2020-04-16 | 2020-04-16 | Influenza virus-like particles (vlps) |
| PCT/EP2021/055928 WO2021209199A1 (en) | 2020-04-16 | 2021-03-09 | Influenza virus-like particles (vlps) |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA202210419B true ZA202210419B (en) | 2023-05-31 |
Family
ID=70292827
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA2022/10419A ZA202210419B (en) | 2020-04-16 | 2022-09-20 | Influenza virus-like particles (vlps) |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20230201336A1 (https=) |
| EP (2) | EP3896077A1 (https=) |
| JP (1) | JP2023526895A (https=) |
| KR (1) | KR20230004675A (https=) |
| CN (1) | CN115427430A (https=) |
| AU (1) | AU2021256266A1 (https=) |
| BR (1) | BR112022020997A2 (https=) |
| CA (1) | CA3172492A1 (https=) |
| IL (1) | IL297272A (https=) |
| MX (1) | MX2022012947A (https=) |
| WO (1) | WO2021209199A1 (https=) |
| ZA (1) | ZA202210419B (https=) |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2278621T5 (es) | 1999-07-14 | 2011-02-02 | Mount Sinai School Of Medicine Of New York University | Reconstrucción in vitro de virus arn segmentados de polaridad negativa. |
| US20070116717A1 (en) | 2005-08-01 | 2007-05-24 | Shneider Alexander M | Influenza vaccine compositions and methods |
| CN102373181B (zh) * | 2010-08-09 | 2014-06-11 | 中山大学 | 猪流感病毒和猪蓝耳病病毒混合病毒样颗粒、制备方法和应用 |
| US9150620B2 (en) * | 2012-04-18 | 2015-10-06 | National Tsing Hua University | Vaccine against multitypes of avian influenza viruses and uses thereof |
| HK1208355A1 (en) * | 2012-11-05 | 2016-03-04 | Georgia State University Research Foundation, Inc. | Universal influenza vaccine based on heterologous multiple m2e proteins |
| US10369216B2 (en) | 2014-04-01 | 2019-08-06 | Curevac Ag | Polymeric carrier cargo complex for use as an immunostimulating agent or as an adjuvant |
| US10494613B2 (en) * | 2015-08-28 | 2019-12-03 | Wisconsin Alumni Research Foundation (Warf) | Generation of infectious influenza viruses from virus-like particles |
| EP3814509A4 (en) | 2018-06-27 | 2022-07-27 | Medicago Inc. | INFLUENCE VIRUS HEMAGGLUTININ MUTANTS |
| WO2020014656A1 (en) | 2018-07-13 | 2020-01-16 | University Of Georgia Research Foundation | Broadly reactive immunogens of influenza h3 virus, compositions and methods of use thereof |
-
2020
- 2020-04-16 EP EP20169787.7A patent/EP3896077A1/en not_active Ceased
-
2021
- 2021-03-09 MX MX2022012947A patent/MX2022012947A/es unknown
- 2021-03-09 AU AU2021256266A patent/AU2021256266A1/en active Pending
- 2021-03-09 CN CN202180028559.3A patent/CN115427430A/zh active Pending
- 2021-03-09 JP JP2022563230A patent/JP2023526895A/ja active Pending
- 2021-03-09 US US17/996,300 patent/US20230201336A1/en active Pending
- 2021-03-09 KR KR1020227040161A patent/KR20230004675A/ko active Pending
- 2021-03-09 BR BR112022020997A patent/BR112022020997A2/pt unknown
- 2021-03-09 IL IL297272A patent/IL297272A/en unknown
- 2021-03-09 WO PCT/EP2021/055928 patent/WO2021209199A1/en not_active Ceased
- 2021-03-09 CA CA3172492A patent/CA3172492A1/en active Pending
- 2021-03-09 EP EP21709710.4A patent/EP4136094A1/en active Pending
-
2022
- 2022-09-20 ZA ZA2022/10419A patent/ZA202210419B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| BR112022020997A2 (pt) | 2022-12-06 |
| JP2023526895A (ja) | 2023-06-26 |
| AU2021256266A1 (en) | 2022-10-13 |
| MX2022012947A (es) | 2022-11-14 |
| EP4136094A1 (en) | 2023-02-22 |
| EP3896077A1 (en) | 2021-10-20 |
| US20230201336A1 (en) | 2023-06-29 |
| KR20230004675A (ko) | 2023-01-06 |
| IL297272A (en) | 2022-12-01 |
| WO2021209199A1 (en) | 2021-10-21 |
| CA3172492A1 (en) | 2021-10-21 |
| CN115427430A (zh) | 2022-12-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP4004036A4 (en) | VIRUS-LIKE PARTICLE VACCINES | |
| IL210215A0 (en) | Influenza virus-like particles (vlps) comprising hemagglutinin | |
| SI2173886T1 (sl) | Delci podobni virusu gripe (VLPs), ki vsebujejo v rastlini proizveden hemagglutin | |
| EP2536428A4 (en) | UNIVERSAL INFLUENZA VACCINES WITH VIRUSIC PARTICLES | |
| LT2635257T (lt) | Pasiutligės glikoproteino į virusą panašios dalelės (vlps) | |
| NZ741875A (en) | Canine parvovirus (cpv) virus-like particle (vlp) vaccines and uses thereof | |
| WO2007130327A3 (en) | Influenza virus-like particle (vlp) compositions | |
| WO2007130330A3 (en) | Polyvalent influenza virus-like particle (vlp) compositions | |
| GB201910651D0 (en) | Virus-like particle | |
| EP3856240A4 (en) | COMPOSITIONS AND METHODS OF MANUFACTURE AND USE OF VIRUS-LIKE PARTICLES (VLPS) | |
| CA3267272A1 (en) | FLU VIRUS VACCINES | |
| EP4380954A4 (en) | SARS-COV-2 PSEUDO-VIRAL PARTICLES | |
| EP3599247A3 (en) | Recombinant hemagglutinin protein of influenza virus and vaccine containing the same | |
| IL308842A (en) | A virus-like particle vaccine for coronavirus | |
| ZA202210419B (en) | Influenza virus-like particles (vlps) | |
| IL321458A (en) | mRNA encoding an influenza virus-like particle | |
| GB202204803D0 (en) | Virus-like particles | |
| EP3170509A4 (en) | Vaccine containing virus-like particles | |
| ZA202209860B (en) | Virus-like particle (vlp), and preparation method and use thereof | |
| GB202005384D0 (en) | Virus-like particles | |
| GB202005385D0 (en) | Virus-like particles | |
| HK40109742A (en) | Virus-like particle vaccine for coronavirus | |
| HK40111727A (en) | Virus-like particle vaccine for respiratory syncytial virus | |
| IL230708A (en) | Influenza virus-like particles containing megalotinin produced in a plant | |
| HK1155480A (en) | Influenza virus-like particles (vlps) comprising hemagglutinin |